BackgroundCardiac resynchronization therapy (CRT) is the recommended treatment by leading
global guidelines. However, 30%-40% of selected patients are non-responders.ObjectiveTo develop an echocardiographic model to predict cardiac death or transplantation
(Tx) 1 year after CRT.MethodObservational, prospective study, with the inclusion of 116 patients, aged 64.89
± 11.18 years, 69.8% male, 68,1% in NYHA FC III and 31,9% in FC IV, 71.55%
with left bundle-branch block, and median ejection fraction (EF) of 29%.
Evaluations were made in the pre-implantation period and 6-12 months after that,
and correlated with cardiac mortality/Tx at the end of follow-up. Cox and logistic
regression analyses were performed with ROC and Kaplan-Meier curves. The model was
internally validated by bootstrapping.ResultsThere were 29 (25%) deaths/Tx during follow-up of 34.09 ± 17.9 months.
Cardiac mortality/Tx was 16.3%. In the multivariate Cox model, EF < 30%, grade
III/IV diastolic dysfunction and grade III mitral regurgitation at 6-12 months
were independently related to increased cardiac mortality or Tx, with hazard
ratios of 3.1, 4.63 and 7.11, respectively. The area under the ROC curve was
0.78.ConclusionEF lower than 30%, severe diastolic dysfunction and severe mitral regurgitation
indicate poor prognosis 1 year after CRT. The combination of two of those
variables indicate the need for other treatment options.